Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL23850306

FC(F)(F)c1cccc(N2CC3(CNC3)C2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.51
▸ HTR3E A5X5Y0 1/20 0.51
▸ HTR3B O95264 1/20 0.51
▸ HTR1D P28221 1/20 0.51
▸ HTR2C P28335 1/20 0.51
▸ HTR3A P46098 1/20 0.51
▸ HTR3D Q70Z44 1/20 0.51
▸ HTR3C Q8WXA8 1/20 0.51
▸ SIGMAR1 Q99720 1/20 0.51
▸ MAPT P10636 2/20 0.50
▸ THRB P10828 1/20 0.50
▸ NOTUM Q6P988 2/20 0.49
▸ CYP3A4 P08684 2/20 0.48
▸ USP2 O75604 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ LMNA P02545 3/20 0.46
▸ HTT P42858 2/20 0.46
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ TSHR P16473 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL20510323 0.85 CYP2C19 (0.50) ALDH1A1CYP3A4USP2HSD17B10TSHR
Trifluoroacetic Acid SCHEMBL23850296 0.79 FFAR4 (0.52) MAPTCYP3A4USP2HSD17B10MEN1
Trifluoroacetic Acid SCHEMBL30059747 0.77 DPP4 (0.48) ALDH1A1TSHRCYP2D6CYP2C9CYP2C19
Trifluoroacetic Acid SCHEMBL21048277 0.77 DPP4 (0.48) ALDH1A1TSHRCYP2D6CYP2C9CYP2C19
Trifluoroacetic Acid SCHEMBL20510269 0.76 CYP2C9 (0.51) ALDH1A1CYP3A4USP2HSD17B10MEN1
Trifluoroacetic Acid SCHEMBL29482892 0.76 CYP3A4 (0.38) ALDH1A1MAPTCYP3A4USP2HSD17B10
Trifluoroacetic Acid SCHEMBL20510487 0.75 MAPK1 (0.39) CYP3A4USP2HSD17B10TSHRCYP2C9
Trifluoroacetic Acid SCHEMBL20510933 0.74 RBP4 (0.39) ALDH1A1CYP3A4USP2HSD17B10TSHR
SCHEMBL23849997 0.72 POLB (0.48) ALDH1A1MAPTCYP3A4HSD17B10LMNA
Trifluoroacetic Acid SCHEMBL20983814 0.72 SMN1; SMN2 (0.49) ALDH1A1MAPTLMNAHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577257-B2 Heterocyclic compounds HOFFMANN-LA ROCHE INC. (US) 2026-03-17 — — US disclosed
EP-3883936-B1 NEW HETEROCYCLIC COMPOUNDS HOFFMANN LA ROCHE (CH) 2023-07-12 — — EP disclosed
US-20210387999-A1 HETEROCYCLIC COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2021-12-16 — — US disclosed
EP-3883936-A1 NEW HETEROCYCLIC COMPOUNDS F. Hoffmann-La Roche AG (CH) 2021-09-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387999-A1 HETEROCYCLIC COMPOUNDS CYP1B1, CYP4B1, CYP4X1 ALDH1A1 492/4885HTR3E 2713/4885HTR3B 1361/4885
US-12577257-B2 Heterocyclic compounds H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR1, CBR3 ALDH1A1 1116/4885HTR3E 1678/4885HTR3B 1565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback